Sep 23, 2020

Proceedings from the tenth in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Dr Emmanuel S Antonarakis, Ms Gretchen Santos Fulgencio, Dr Kathleen Moore, Dr Joyce O’Shaughnessy, Dr Michael J Pishvaian and Ms Deborah Wright.

• Introduction (00:00)
• Overview of PARP Inhibitors — Biologic Rationale and Mechanism of Action (4:44)
• Side Effects and Toxicities of PARP Inhibitors (30:04)
• PARP Inhibitors for Ovarian Cancer (34:09)
• PARP Inhibitors for Breast Cancer (54:01)
• PARP Inhibitors for Pancreatic Cancer (1:01:18)
• PARP Inhibitors for Prostate Cancer (1:11:15)

CNE information and select publications